U.S., Sept. 24 -- An application to own the trademark for 'OXEIA' has been filed on Oct. 28, 2021.
Owner(s):
Oxeia Biopharmaceuticals, Inc.; 361 Newbury Street, Suite 500, , MASSACHUSETTS
Goods and/or Services:
For: Pharmaceutical preparations for treating neurotrauma and neuro-metabolic dysfunction; pharmaceutical preparations for treating concussions, brain injuries and dysfunctions, neurodegeneration, and neurologic diseases, conditions, and disorders; therapeutic preparations, namely, endogenous hormones and synthetic human ghrelin for stabilizing brain metabolism and energy.
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Pharmaceutical research and development; providing medical and scientific research information in the field...